Join the Dalfampridine group to help and get support from people like you.
Dalfampridine News
FDA Medwatch Alert: Ampyra (dalfampridine): Drug Safety Communication - Seizure Risk for Multiple Sclerosis Patients
ISSUE: FDA is updating health care professionals and the public about the risk of seizures in patients with multiple sclerosis (MS) who are starting Ampyra (dalfampridine). Using information received...
Ask a question
To post your own question to this support group, sign in or create an account.